199 related articles for article (PubMed ID: 11069384)
1. Comparison of the effects of novel antimuscarinic drugs on human detrusor smooth muscle.
Yono M; Yoshida M; Takahashi W; Inadome A; Ueda S
BJU Int; 2000 Oct; 86(6):719-25. PubMed ID: 11069384
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of tolterodine on human isolated urinary bladder.
Yono M; Yoshida M; Wada Y; Kikukawa H; Takahashi W; Inadome A; Seshita H; Ueda S
Eur J Pharmacol; 1999 Mar; 368(2-3):223-30. PubMed ID: 10193658
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic actions of temiverine (p-INN) and its active metabolite, RCC-36, on isolated human urinary bladder muscle.
Kikukawa H; Yoshida M; Wada Y; Nishi K; Ueda S
Int J Urol; 1998 May; 5(3):268-75. PubMed ID: 9624560
[TBL] [Abstract][Full Text] [Related]
4. Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse.
Wüst M; Averbeck B; Reif S; Bräter M; Ravens U
Eur J Pharmacol; 2002 Nov; 454(1):59-69. PubMed ID: 12409006
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats.
Sugiyama Y; Yoshida M; Masunaga K; Satoji Y; Maeda Y; Nagata T; Inadome A; Ueda S
Int J Urol; 2008 Jan; 15(1):76-81. PubMed ID: 18184179
[TBL] [Abstract][Full Text] [Related]
6. Tolterodine--a new bladder-selective antimuscarinic agent.
Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological effects of solifenacin on human isolated urinary bladder.
Masunaga K; Yoshida M; Inadome A; Murakami S; Sugiyama Y; Satoji Y; Maeda Y; Ueda S
Pharmacology; 2008; 82(1):43-52. PubMed ID: 18434763
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Ohtake A; Saitoh C; Yuyama H; Ukai M; Okutsu H; Noguchi Y; Hatanaka T; Suzuki M; Sato S; Sasamata M; Miyata K
Biol Pharm Bull; 2007 Jan; 30(1):54-8. PubMed ID: 17202659
[TBL] [Abstract][Full Text] [Related]
9. The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia.
Yamanishi T; Kaga K; Fuse M; Shibata C; Kamai T; Uchiyama T
J Pharmacol Sci; 2015 Jun; 128(2):65-70. PubMed ID: 26084660
[TBL] [Abstract][Full Text] [Related]
10. Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine.
Nilvebrant L; Gillberg PG; Sparf B
Pharmacol Toxicol; 1997 Oct; 81(4):169-72. PubMed ID: 9353847
[TBL] [Abstract][Full Text] [Related]
11. Tolterodine and its active 5-hydroxymethyl metabolite: pure muscarinic receptor antagonists.
Nilvebrant L
Pharmacol Toxicol; 2002 May; 90(5):260-7. PubMed ID: 12076307
[TBL] [Abstract][Full Text] [Related]
12. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction.
Kaiho Y; Nishiguchi J; Kwon DD; Chancellor MB; Arai Y; Snyder PB; Yoshimura N
BJU Int; 2008 Mar; 101(5):615-20. PubMed ID: 18070178
[TBL] [Abstract][Full Text] [Related]
13. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
Kim Y; Yoshimura N; Masuda H; de Miguel F; Chancellor MB
Urology; 2005 Feb; 65(2):238-42. PubMed ID: 15708029
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological effects of darifenacin on human isolated urinary bladder.
Miyamae K; Yoshida M; Murakami S; Iwashita H; Ohtani M; Masunaga K; Ueda S
Pharmacology; 2003 Dec; 69(4):205-11. PubMed ID: 14624061
[TBL] [Abstract][Full Text] [Related]
15. Actions of the new antimuscarinic compound Lu 25-109 on isolated human and pig detrusor.
Waldeck K; Larsson B; Sandberg B; Andersson K-
Neurourol Urodyn; 2002; 21(1):92-8. PubMed ID: 11835429
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of various anticholinergic drugs on human isolated urinary bladder.
Wada Y; Yoshida M; Kitani K; Kikukawa H; Ichinose A; Takahashi W; Gotoh S; Inadome A; Machida J; Ueda S
Arch Int Pharmacodyn Ther; 1995; 330(1):76-89. PubMed ID: 8849312
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells.
Kobayashi S; Ikeda K; Miyata K
Life Sci; 2004 Jan; 74(7):843-53. PubMed ID: 14659973
[TBL] [Abstract][Full Text] [Related]
18. Juvenile pig detrusor: effects of propiverine and three of its metabolites.
Wuest M; Braeter M; Schoeberl C; Ravens U
Eur J Pharmacol; 2005 Nov; 524(1-3):145-8. PubMed ID: 16256104
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
Gillberg PG; Sundquist S; Nilvebrant L
Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
[TBL] [Abstract][Full Text] [Related]
20. Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
Kim Y; Yoshimura N; Masuda H; De Miguel F; Chancellor MB
BJU Int; 2006 Feb; 97(2):400-3. PubMed ID: 16430654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
